MarketCapExport financials
China Jo-Jo Drugstores, Inc. (CJJD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
TelegramChina Jo-Jo Drugstores, Inc. Financial Ratios 2020-2011 | CJJD
Brief overview of China Jo-Jo Drugstores, Inc.'s multiples and efficiency
The review covers five available annual periods spanning 2011 to 2019.
The valuation comparison uses P/E 59.75x (median 32.02x), EV/EBITDA 68.51x (median 14.03x), P/S 0.63x (median 0.37x). On average, this basket is 113.3% above its own five-year medians. The market is pricing in elevated future expectations.
The inverse P/E implies an earnings yield of 1.7%. This is not a dividend yield, but current earnings relative to market price.
Returns on assets and capital are represented by ROE -31%, ROA -5.8%, ROCE -16.6%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.
On PEG (0.43x), valuation is restrained relative to growth, but one ratio cannot replace cash-flow and risk analysis.
What the ratios show
China Jo-Jo Drugstores, Inc. combines weak profitability with valuation above its historical norm, leaving limited cushion.
Annual Financial Ratios China Jo-Jo Drugstores, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -12.8 | -41.2 | -2.1 | -6.4 | 59.8 | 66.4 | -1114786.9 | -0.6 | 1.8 | 4.3 | |
P/S |
0.6 | 0.4 | 0.4 | 0.4 | 0.3 | 0.7 | 427727.9 | 0.1 | 0.2 | 0.5 |
EV/EBITDA |
-13.4 | 68.5 | -2.4 | -6.4 | 14.0 | 15.2 | -1300669.9 | -1.0 | 1.1 | 2.6 |
PEG |
-0.03 | 0.43 | -0.01 | 0.01 | -1.16 | -0.64 | -15107.75 | 0.0 | -0.32 | -0.1 |
P/B |
4.0 | 2.3 | 1.9 | 1.4 | 1.4 | 3.3 | 1971289.6 | 0.2 | 0.3 | 0.9 |
P/CF |
-8.1 | -3.0 | -7.1 | 31.6 | 11.4 | -28.5 | -19816006.9 | -3.3 | 1.7 | -3.7 |
ROE % |
-30.96 | -5.46 | -90.44 | -21.17 | 2.31 | 4.97 | -176.83 | -37.49 | 15.47 | 19.97 |
ROA % |
-5.84 | -1.27 | -23.11 | -8.40 | 0.72 | 1.44 | -55.33 | -21.08 | 10.81 | 15.57 |
ROCE % |
-16.64 | -5.00 | -94.84 | -22.45 | -0.12 | 3.73 | -170.73 | -36.95 | 20.04 | 27.48 |
DSO |
46.3 | 45.2 | 44.4 | 49.6 | 38.7 | 49.9 | 38.0 | 53.6 | 66.2 | 13.2 |
DIO |
48.7 | 61.8 | 64.5 | 55.8 | 55.1 | 59.7 | 50.9 | 41.8 | 37.6 | 34.5 |
DPO |
85.7 | 102.3 | 121.3 | 109.4 | 85.0 | 90.1 | 88.0 | 67.2 | 76.0 | 26.4 |
Annual performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company China Jo-Jo Drugstores, Inc., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Pharmaceutical retailers industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
LifeMD
LFMD
|
$ 1.7 | -18.74 % | $ 76.7 M |  USA |
 |
Аптеки 36.6
APTK
|
- | - | - |  Russia |
 |
Greenlane Holdings
GNLN
|
$ 1.14 | -1.72 % | $ 8.54 M | USA |
 |
BOQI International Medical
BIMI
|
- | 6.33 % | $ 5.86 M |  China |
 |
Rite Aid Corporation
RAD
|
- | - | $ 35.5 M | USA |
 |
Walgreens Boots Alliance
WBA
|
- | - | $ 10.3 B | USA |
 |
PetMed Express
PETS
|
$ 1.24 | -0.8 % | $ 25.9 M | USA |
 |
111
YI
|
$ 2.95 | 0.72 % | $ 513 M | China |
 |
Trxade Group
MEDS
|
- | 4.55 % | $ 5.8 M | USA |